Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1621 to 1635 of 2006 results for nice guidelines

  1. Parent-training/education programmes in the management of children with conduct disorders (TA102)

    This guidance has been updated and replaced by NICE guideline CG158.

    Withdrawn guidance

  2. Statins for the prevention of cardiovascular events (TA94)

    This guidance has been updated and replaced by NICE guideline CG181.

    Withdrawn guidance

  3. Faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection (MIB247)

    This advice has been updated and replaced by NICE guideline NG199.

    Withdrawn advice

  4. Community engagement (PH9)

    This guidance has been updated and replaced by NICE guideline NG44.

    Withdrawn guideline

  5. Looked-after children and young people (PH28)

    This guidance has been updated and replaced by NICE guideline NG205.

    Withdrawn guideline

  6. Sexually transmitted infections and under-18 conceptions: prevention (PH3)

    This guidance has been updated and replaced by NICE guideline NG221.

    Withdrawn guideline

  7. Substance misuse interventions for vulnerable under 25s (PH4)

    This guidance has been updated and replaced by NICE guideline NG64.

    Withdrawn guideline

  8. HIV testing: increasing uptake in black Africans (PH33)

    This guidance has been updated and replaced by NICE guideline NG60.

    Withdrawn guideline

  9. Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: early value assessment (HTG746)

    Early value assessment (EVA) guidance on artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway.

    HealthTech guidance
    Published
    1 May 2025
    View recommendations

    Sections for HTG746

  10. Improving outcomes in colorectal cancer (CSG5)

    This guidance has been updated and replaced by NICE guideline NG151.

    Withdrawn guideline

  11. Attention deficit hyperactivity disorder: diagnosis and management (CG72)

    This guidance has been updated and replaced by NICE guideline NG87.

    Withdrawn guideline

  12. Surgical site infections: prevention and treatment (CG74)

    This guidance has been updated and replaced by NICE guideline NG125.

    Withdrawn guideline

  13. Glaucoma: diagnosis and management (CG85)

    This guidance has been updated and replaced by NICE guideline NG81.

    Withdrawn guideline

  14. Febuxostat for the management of hyperuricaemia in people with gout (TA164)

    This guidance has been updated and replaced by NICE guideline NG219.

    Withdrawn guidance

  15. Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure (TA48)

    This guidance has been updated and replaced by NICE guideline NG107 

    Withdrawn guidance